Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 37 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

22%

8 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
13(46.4%)
Phase 3
4(14.3%)
Phase 4
4(14.3%)
Phase 2
4(14.3%)
Phase 1
3(10.7%)
28Total
N/A(13)
Phase 3(4)
Phase 4(4)
Phase 2(4)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (37)

Showing 20 of 37 trials
NCT06434649Not ApplicableActive Not Recruiting

Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer

Role: collaborator

NCT07212569Not Yet Recruiting

Analysis of Differences in Small Intestinal Microbiota Structure and Metabolites Between Patients With Irritable Bowel Syndrome and Healthy Individuals

Role: lead

NCT07045883Not ApplicableActive Not Recruiting

Mechanism and Application of Vitamin D in Idiopathic Sudden Sensorineural Hearing Loss

Role: lead

NCT04823468Not ApplicableCompleted

Effect of Oral Nutritional Supplements on Body Weight Loss of Patients With Nasopharyngeal Carcinoma

Role: collaborator

NCT04624763Not ApplicableActive Not Recruiting

Protection of Cardiac Function With Left Bundle Branch Pacing in Patients With Atrioventricular Block

Role: collaborator

NCT06431542Phase 4Completed

Efficacy of Self Vs. Physician Application of Triamcinolone-Econazole in Otomycosis

Role: lead

NCT06629051Recruiting

6-year Follow-up Data After the Berberine Intervention Trial

Role: collaborator

NCT06530069Recruiting

Exploring the Risk Factors of Otomycosis: A Case-Control Study

Role: lead

NCT03151278Not ApplicableCompleted

Zero Fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for Right Atrial Arrhythmias

Role: collaborator

NCT04521205Phase 1Unknown

A Multicenter Clinical Trial: Efficacy, Safety of Fecal Microbiota Transplantation for Inflammatory Bowel Disease

Role: lead

NCT03426683Not ApplicableCompleted

The Effect of Intestinal Microbiota Transplantation for Inflammatory Bowel Diseases

Role: lead

NCT05986383Unknown

Multi-center Clinical Study on the Decision Tree of Precision Hepatectomy in China Precision Hepatectomy Decision Tree

Role: collaborator

NCT05159947Phase 3Unknown

SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial

Role: collaborator

NCT05637021Unknown

Effect of Carbon Dioxide Insufflation and Appendix on the Restoration of Intestinal Microecology After Colonoscopy.

Role: lead

NCT04922567Phase 2Recruiting

Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Role: collaborator

NCT05465889Phase 3Completed

Efficacy and Safety of Oral Sulfate Solution on Bowel Preparation for Colonoscopy

Role: collaborator

NCT05441254Phase 2Unknown

Camrelizumab Combined With Intraperitoneal Infusion of Nab-paclitaxel, Intravenous Chemotherapy and S-1 in the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis:Single-arm, Prospective Clinical Study

Role: lead

NCT05400928Not ApplicableUnknown

The Effect and Safety of Pulsed Field Ablation (PFA) in Patients With Paroxysmal Atrial Fibrillation (PAF)

Role: collaborator

NCT05274191Phase 2Unknown

An Exploratory Basket Study of Pyrotinib Maleate Tablets in HER2 Mutated or Amplified of Metastatic Solid Tumors

Role: lead

NCT05247476Phase 4Unknown

Type 2 Deiodinase Gene Polymorphism and the Treatment of Hypothyroidism Caused by Thyroidectomy in Thyroid Cancer Patients.

Role: lead